Bacterial lipopolysaccharide protects gastric mucosa against acute injury in rats by activation of genes for cyclooxygenases and endogenous prostaglandins

Digestion

Volumn 59, Issue 4, 1998, Pages 284-297

  Konturek, Peter Ch ^a,c   Brzozowski, Tomasz ^b   Konturek, Stanislaw J ^b   Taut, Astrid ^a   Kwiecien, Slawomir ^b   Pajdo, Robert ^b   Sliwowski, Zbigniew ^b   Hahn, Eckhart G ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c Department of Medicine I ^*  (Germany)

Author keywords

Cyclooxygenase 1; Cyclooxygenase 2; Gastric blood flow; Gastroprotection; Indomethacin; Lipopolysaccharide; Meloxicam; Prostaglandins; RT PCR

Indexed keywords

ALCOHOL; BACTERIUM LIPOPOLYSACCHARIDE; INDOMETACIN; MELOXICAM; MESSENGER RNA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PEPSIN A; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; HYPEREMIA; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PEPSIN SECRETION; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RADIOIMMUNOASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH ACID SECRETION; STOMACH BLOOD FLOW; STOMACH INJURY; STOMACH MUCOSA; STOMACH SECRETION;

ANIMALS; BLOOD FLOW VELOCITY; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; ESCHERICHIA COLI; ETHANOL; GASTRIC MUCOSA; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INDOMETHACIN; ISOENZYMES; LIPOPOLYSACCHARIDES; MALE; MEMBRANE PROTEINS; NITROBENZENES; POLYMERASE CHAIN REACTION; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, WISTAR; RNA, MESSENGER; SOLVENTS; SULFONAMIDES; THIAZINES; THIAZOLES;

EID: 0031877059     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007505     Document Type: Article

References (43)

1. Warren JR, Marshall BJ: Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;i:1273.
2. Dekigai H, Murakami M, Kita T: Mechanism of Helicobacter pylori associated gastric mucosa injury. Dig Dis Sci 1995;40:1332-1339.
3. Figura N, Tabaqchali S: Bacterial pathogenic factors. Curr Opin Gastroenterol 1996;12 (suppl):11-15.
4. Rietschel ET, Brade L, Holst O, et al: Molecular structure of bacterial endotoxin in relation to bioactivity; in Nowotny A, Spitzer JJ, Ziegler EJ (eds): Cellular and Molecular Aspects of Endotoxin Reactions, Endotoxin Research Series. Amsterdam, Elsevier Science, 1990, vol 1, pp 15-32.
5. Moran AP: The role of lipopolysaccharide in Helicobacter pylori pathogenesis. Aliment Pharmacol Ther 1996;10(suppl 1):39-50.
6. Aspinal GO, Monteiro MA, Pang H, Walsh EJ, Moran AP: O antigen chains in the lipopolysaccharide of Helicobacter priori NCCT. 11637. Carbohydr Lett 1995;1:151-156.
7. Slomiany BL, Piotrowski J, Sengupta S, Slomiany A: Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccha-ride. Biochem Biophys Res Commun 1991; 175:963-970.
8. Ferraz JG, Sharkey KA, Reuter BK, Asfaha S, Tigley AW, Brown ML, McKnight SW, Wallace JL: Induction of cyclooxygenase 1 and 2 in the rat stomach during endoxemia: Role of resistance to damage. Gastroenterology 1997; 113:195-204.
9. Tepperman BL, Soper BD: Nitric oxide synthase induction and cytoprotection of rat gastric mucosa from injury by ethanol. Can J Physiol Pharmacol 1994;72:1308-1312.
10. O'Sullivan MG, Chilton FH, Huggins EM Jr, McCall CE: Lipopolysaccharide priming of alveolar macrophages for enhanced synthesis of prostanoids involves induction of a novel prostaglandin H synthase. J Biol Chem 1992;267: 14547-14550.
11. Lee SH, Soyoola P, Chanmugam S, Hart S, Sun W, Zhong H, Simmons D, Hang D: Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem 1992;267:25934-25938.
12. Brown JF, Tepperman BL, Hanson PJ, Whittle BJ: Lipopolysaccharide induced Ca2+-independent nitric oxide synthase activity in rat gastric mucosal cells. Eur J Pharmacol 1994; 292:111-114.
13. Yokayama C, Tanable T: Cloning of human gene encoding prostaglandin endoperoxidase synthase and primary structure of the enzyme. Biochem Biophys Res Commun 1989;165: 888-894.
14. Williams CW, DuBois RN: Prostaglandin endoperoxide synthase: Why two isoforms? Am J Physiol 1996;270:G393-G400.
15. Crofford LJ, Wilder RL, Ristimaki AP, Sano H, Remmers EF, Epps HR, Hla T: Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester and corticosteroids. J Clin Invest 1994;93:1095-1101.
16. Ristmaki A, Wilder RL, Wessendorf J: Induction of cyclooxygenase-2 by interleukin-alpha. Evidence for post-translational regulation. J Biol Chem 1994;269:U769-U775.
17. Masferrer JL, Zweifel BS, Manning PA, Hauser SD, Leahy KM, Smith WG, Isakson PC, Seibert K: Selective inhibition of inducible cyclooxygenase-2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci USA 1994;91:3228-3232.
18. Donnelly MT, Hawkey CJ: Review article. COX-II inhibitors: A new generation of safer NSAIDs? Aliment Pharmacol Ther 1997;11: 227-236.
19. Reuter BK, Asfaha S, Buret A, Sharkey KA, Wallace JL: Exacerbation of inflammation-associated colonie injury in rat through inhibition of cyclooxygenase-2. J Clin Invest 1996; 98:2076-2085.
20. Konturek SJ, Brzozowski T, Konturek P, Maijka J, Dembinski A: Role of salivary glands and epidermal growth factor in gastric secretions and mucosal integrity in rats exposed to stress. Regul Pept 1991;32:203-215.
21. Brzozowski T, Konturek P, Sliwowski Z, Szlachcic A, Hahn EG, Konturek SJ: Adaptive cytoprotection by ammonia and urea-urease system in the rat gastric mucosa. J Physiol Pharmacol 1995;46:471-488.
22. Konturek SJ, Brzozowski T, Pytko-Polonczyk J, Drozdowicz D: Exogenous and endogenous cholecystokinin protects gastric mucosa against the damage caused by ethanol in rats. Eur J Pharmacol 1995;273:57-62.
23. Konturek SJ, Brzozowski T, Stachura J, Dembinski A, Majka J: Role of gastric blood flow, neutrofil infiltration and mucosal cell proliferation in gastric adaptation to aspirin in the rat. Gut 1994;35:1189-1196.
24. Brzozowski T, Konturek PC, Konturek SJ, Ernst H, Stachura J, Hahn EG: Gastric adaptation to injury by repeated doses of aspirin strengthens mucosal defense against subsequent exposure to various strong irritant in rats. Gut 1995;37:749-757.
25. Mitchell JA, Akarasereeont P, Thiemermann C, Flower RJ, Vane JR: Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1993;90:11693-11697.
26. Feng L, Sun W, Xia Y, Tang WW, Chanmugam P, Soyoola E, Wilson CB, Hwang D: Cloning two isoforms of rat cyclooxygenase: Differential regulation of their expression. Arch Biochem Biophys 1992;307:361-368.
27. Kennedy BP, Chan CC, Culp SA, Cromlish WA: Cloning and expression of rat prostaglandin endoperoxide synthase (cyclooxygenase)-2 cDNA. Biochem Biophys Res Commun 1993; 197:494-500.
28. O'Banion MK, Winn VD, Young DA: Cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc Natl Acad Sci 1992;89:4888-4892.
29. Wang QS, Sabourin LK, Bijur GM, Robertson FM, Stoner GD: Alterations in transforming growth factor-α and epidermal growth factor receptor expression during rat esophageal tumorigenesis. Mol Carcinog 1996;15:144-153.
30. Tanoue K, Masayuki O, Tarnawski A, Wahlstrom IV, Sugimachi K, Sarferh IJ: Portal hypertension activates the nitric oxide synthase genes in the esophageal mucosa of rats. Gastroenterology 1996;110:549-557.
31. Eberhart CE, DuBois RN: Eicosanoids and gastrointestinal tract. Gastroenterology 1995;109: 285-301.
32. Bennett A, Hensly CN, Sanger GJ: Metabolites of arachidonic acid formed by human gastrointestinal tissues and their actions on smooth muscles layers. Br J Pharmacol 1981;74:435-444.
33. Rask-Madsen J: The role of eicosanoids in the gastrointestinal tract. Scand J Gastroenterol 1987;22(suppl 127):7-19.
34. Smith WL, Meade EA, DeWitt DL: Pharmacology of prostaglandin synthase isoenzymes-1 and-2. Ann NY Acad Sci 1994;714:136-142.
35. Vane JR, Bolting RM: A better understanding of anti-inflammatory drugs based on isoforms of cyclooxygenase (COX-1 and COX-2). Adv Prostaglandin Thromboxane Leukot Res 1995; 23:41-48.
36. Wallace JL: Nonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred years. Gastroenterology 1997;112: 1000-1016.
37. Ristimaki A, Garfmkel S, Wessendorf J, Maciag T, Hla T: Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for post-transcriptional regulation. J Biol Chem 1994;269: 11769-11775.
38. Masferrer JL, Isakson PC, Seibert K: Cyclooxygenase-2 inhibitors. A new class of anti-inflammatory agents that spare the gastrointestinal tract. Gastroenterol Clin North Am 1996;25: 363-372.
39. Chan CC, Boyce S, Brideau C, Ford-Hutchinson AW, Gordon R, Guay D, Hill RG, Li CS, Mancini J, Penneton M: Pharmacology of a selective cyclooxygenase-2-inhibitor, L-745,337: A novel nonsteroidal antiinflammatory agent with an ulcerogenic sparing effect in rat and non-human primate stomach. J Pharmacol Exp Ther 1995;274:1531-1537.
40. Nanji AA, Miao L, Thomas P, Rahemtulla A, Khwaja S, Zhao S, Peters D, Tahan SR, Dannenberg AJ: Enhanced cyclooxygenase-2 expression in alcoholic liver disease in the rat. Gastroenterology 1997;112:943-951.
41. Davies NM, Sharkey KA, Asfaha S, Mac-Naughton WK, Wallace JL: Aspirin causes rapid upregulation of cyclooxygenase-2 expression in the stomach of rats. Aliment Pharmacol Ther 1997;11:1101-1108.
42. Salvemini D, Misko TP, Seibert K, Masferrer JL, Currie MG, Needleman P: Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 1993;90:7240-7244.
43. Wallace JL: Nonsteroidal antiinflammatory drugs and gastroenteropathy: The second hundred years. Gastroenterology 1997;110: 549-557.